Analyst consensus rating

Apnimed Analyst Rating: none

Direct answer

Apnimed's consensus rating is none.

3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $50.33.
Forecast evidence checked November 17, 2026.

Get free Apnimed email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$16.28
Average price target
$50.33
High price target
$60.00
Low price target
$41.00
Low target gap
+151.8%
Target upside
+209.2%
High target gap
+268.6%
Target range width
116.7%
Consensus rating
none
Analysts
3
Evidence date
November 17, 2026
Valid through
November 24, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Apnimed?

Apnimed has a verified none consensus. The same dataset has an average price target of $50.33.

How far are Apnimed's low and high targets from the recorded price?

The low target implies +151.8%, while the high target implies +268.6%.

How many analysts are included in Apnimed's consensus?

The verified consensus includes 3 analysts.

How is Apnimed's target upside or downside calculated?

The average target of $50.33 is divided by the recorded price of $16.28, then one is subtracted to produce +209.2%. This does not guarantee a future return.

When was Apnimed's analyst forecast verified?

The data was verified on 2026-11-17. The dataset is valid through 2026-11-24.